Yannelli, co-founder and CTO of Nextvisit, a clinical documentation platform built exclusively for behavioral health, has identified six factors he says separate effective mental health AI scribes from general-purpose tools that often fail in psychiatric settings.
“General-purpose AI scribes struggle with basic psychiatric terminology like affect, thought process, and suicidal ideation,” Yannelli said. “They miss the context that differentiates a medication management visit from an initial psychiatric evaluation. When this happens it degrades provider confidence in workflow automation. Behavioral health providers deserve tools designed from the ground up for how they actually practice.”
The documentation burden in behavioral health has reached a critical point. According to the American Psychological Association’s 2024 Practitioner Pulse Survey, one in three psychologists report feeling burned out. The American Psychiatric Association reports two in five psychiatrists are affected by professional burnout. Clinicians routinely spend 10 to 15 minutes per session note, translating to more than four hours of documentation time weekly for providers seeing 25 patients.
Yannelli’s six critical evaluation factors include specialty-specific design for behavioral health workflows, SOAP note and intake note quality, HIPAA compliance and security certifications including SOC 2 Type II, EHR integration capabilities, transparent pricing models, and accuracy with nuanced clinical content.
Dr. Faisal Rafiq, a practicing psychiatrist and Nextvisit’s co-founder and CEO, emphasized the clinical stakes involved in choosing the right tool.
“Sessions run 45 to 60 minutes and cover trauma, medication side effects, and therapeutic progress,” Dr. Rafiq said. “There is no quick checkbox approach to psychiatric documentation. An AI scribe that cannot transform a 60-minute intake into comprehensive documentation is not ready for behavioral health.”
Yannelli noted that mental health data requires heightened security standards beyond basic HIPAA compliance. He recommends providers verify SOC 2 certification, understand data retention policies, and confirm whether patient data is used to train AI models. For practices treating substance use disorders, 42 CFR Part 2 compliance adds additional privacy requirements that most general medical scribes do not address.
“A tool priced at $10 per session sounds affordable until a clinician realizes they’re seeing 100 sessions monthly,” Yannelli said. “Providers need to calculate total monthly costs based on actual session volume before committing.”
Looking ahead to 2026, Yannelli predicts continued evolution in the AI scribe market, with emerging capabilities including longitudinal patient insights that surface patterns across sessions, group therapy documentation support, and tighter integration between documentation and billing workflows.
About Nextvisit
Nextvisit is an AI-powered clinical documentation platform with a built-in medical AI scribe, built exclusively for behavioral health. Co-founded by Dr. Faisal Rafiq, a practicing psychiatrist, and Ryan Yannelli, a health technology engineer, Nextvisit transforms patient conversations into accurate SOAP notes and intake documentation, giving providers time back for patient care. The company recently graduated from Jason Calacanis’ LAUNCH Accelerator as part of the LA35 cohort.
Media Contact
Nextvisit AI
Ryan Yannelli
+1 (877) 703-7477
ryan@nextvisit.ai
Press Release Distributed by PRLog
Source: Nextvisit AI
Follow the full story here: https://przen.com/pr/33601569
